Pharmacological targeting of IRE1 in cancer
IRE1α (inositol requiring enzyme 1 alpha) is one of the main transducers of the unfolded protein response (UPR). IRE1α plays instrumental protumoral roles in several cancers, and high IRE1α activity has been associated with poorer prognoses. In this context, IRE1α has been identified as a potentiall...
Main Authors: | Pelizzari Raymundo, D, Doultsinos, D, Guillory, X, Carlesso, A, Eriksson, LA, Chevet, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Cell Press
2020
|
Similar Items
-
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment
by: Diana Pelizzari-Raymundo, et al.
Published: (2023-05-01) -
Peptidomimetic‐based identification of FDA approved compounds inhibiting IRE1 activity
by: Doultsinos, D, et al.
Published: (2020) -
Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein response
by: Kosala N. Amarasinghe, et al.
Published: (2022-01-01) -
Different binding modalities of quercetin to inositol-requiring enzyme 1 of S. cerevisiae and human lead to opposite regulation
by: S. Jalil Mahdizadeh, et al.
Published: (2024-01-01) -
Dual IRE1 RNase functions dictate glioblastoma development
by: Stéphanie Lhomond, et al.
Published: (2018-01-01)